Emily Taylor – Trademark Portfolio

Entity Type: 99

Emily Taylor holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 4 filings in this category. The portfolio also extends into Class 24 (Fabrics) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include GINJECTOR and THE CLEAN EAR CLUB. The owner is based in Longmeadow, MA.

523 Laurel Avenue

Longmeadow, MA 01106

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Emily Taylor's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

44
Medical Services (4 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

24
Fabrics (1 filing)

Textiles and textile goods; bed covers; table covers

14
Jewelry (1 filing)

Precious metals and their alloys; jewellery, precious stones; horological instruments

Frequently Asked Questions

How many trademarks does Emily Taylor have?

Emily Taylor has 5 U.S. trademarks filed with the USPTO. Of these, 2 registered, 3 abandoned.

What trademark classes does Emily Taylor file in?

Emily Taylor files trademarks across 3 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 24 (Fabrics), Class 14 (Jewelry). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.

What are Emily Taylor's most well-known trademarks?

Emily Taylor's registered trademark portfolio includes well-known marks such as GINJECTOR and THE CLEAN EAR CLUB. These are among 2 currently registered trademarks in the portfolio.

What is Emily Taylor's trademark registration success rate?

Emily Taylor has a 40% trademark registration rate, with 2 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.